COMPLEX DIAGNOSTIC APPROACH AND DIFFERENTIAL TREATMENT OF PATIENTS WITH SYMPTOMATIC AND DRUG-RESISTANT EPILEPSY. (REVIEW ARTICLE)
Keywords:
Epilepsy, drug resistant, epilepsy surgeryAbstract
Epilepsy is one of the most common and chronic neurological disorders that can affect people in any age group. Despite the emergence of new antiepileptic drugs for the treatment of epilepsy, the level of drug-resistant forms of epilepsy is quite high, which is 30% of the total number of patients with epilepsy. Therefore, early detection of drug-resistant epilepsy and timely referral of patients to surgical treatment leads to decrease and disappearance of epileptic seizuresand improvement in the social readaptation of patients with epilepsy.
References
Бехтерев В.М. Случай операции при эпилепсии. Врач. 1895;17:488. [Bekhterev VM. Sluchai operatsii pri epilepsii. Vrach. 1895;17:488. (InRuss.).
Докукина Т. В., Голубева Т. С., Матвейчук И. В., Махров М. В., Лосева В. М., Крупенькина Е. В., Марчук С. А. Результаты фармакоэпидемиологического исследования эпилепсии в Белоруссии. ФАРМАКОЭКОНОМИКА. Современная Фармакоэкономика и фармакоэпидемиология. 2014; 7 (2): 33-37.
Карлов В.А. Фармакорезистентность и толерантность. Эпилепсия у детей и взрослых женщин и мужчин. Руководство для врачей. М.: Медицина; 2010.
Кариев Г.М. Якубов Ж.Б. Арсланова З.Э. Эволюция хирургического лечения эпилепсии с первых дней до современных тенденций (обзор литературы) Журнал теоретической и клинической медицины. № 4, 2014, Ст: 56-62.
Крылов В.В., Гехт А.Б., Трифонов И.С, и соавт. Клинические рекомендации по предоперационному обследованию и хирургическому лечению пациентов с фармакорезистентными формами эпилепсии. 2015г.)
Крылов В.В., Гусев Е.И., Гехт А.Б., Трифонов И.С., Лебедева А.В., Каймовский И.Л. История развития хирургического лечения эпилепсии в Российской Федерации. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116 (9-2):6-12.https://doi.org/10.17116/jnevro2016116926-12.
Маматханов М.Р. Хирургическое лечение фармакорезистентных форм эпилепсии у детей. Автореферат. Санкт-Петербург 2020.
Назарова Л.А. автореферат - Уровень оказания нейрохирургической помощи на момент становления нейрохирургии в Ташкенте (1919-1943). 2013; 54-55.
Общество доказательной неврологии. https://evidence-neurology.ru/evidentiary-medicine/nosology/epilepsy/klassifikatsiia-epilepsii).
Asadi-Pooya A, Rostami C. History of surgery for temporal lobe epilepsy. Epilepsy&Behavior. 2017;70:57-60. https://doi.org/10.1016/j.yebeh.2017.02.020.
Avakyan G. N. Issues of modern epileptology. Epilepsiya i paroksizmal’nye sostoyaniya / Epilepsy and paroxysmal conditions. 2015; 7 (4): 16-21.
Banerjee P, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy. A review. Epilepsy Res. 2009;85(1):31-45. https://doi.org/10.1016/j.eplepsyres.2009.03.003.
Bell G. S., Neligran A., Sander J. W. An unknown quantity – the worldwide prevalence of epilepsy. Epilepsia. 2014; 55 (7): 958-962.
Berg AT. Defining intractable epilepsy. AdvNeurol. 2006;97:5-10.
Bidziński J. History of the surgical treatment of epilepsy. NeurolNeurochir Pol. 1998;32(suppl 2):13-23.
Blumenfeld H. Whatis a seizurenetwork? Long-range network consequences of focal seizures. AdvExp Med Biol 2014; 813:63–70.
de Almeida A, Teixeira M, Feindel W. From lateral to mesial: The quest for a surgical cure for temporal lobe epilepsy. Epilepsia. 2008;49(1):98-107. https://doi.org/10.1111/j.1528-1167.2007.01321.x.
DudleyB.W. Observations on injuries of the head. Transylvania J Med. 1828; 1:9-40.
Dwivedi et al.,Surgery for Drug-Resistant Epilepsy in Children.Randomized Controlled Trial N Engl J Med. 2017 Oct 26;377(17):1639-1647. doi: 10.1056/NEJMoa1615335. 2017
England, M.J., Liverman, C.T., Schultz, A.M., and Strawbridge, L.M. (2012). Epilepsy across the spectrum: promoting health and understanding. Epilepsy Behav. (2): 266–276.
Fiest, K.M., Sauro, K.M., Wiebe, S. et al. (2017). Prevalence and incidence of epilepsy a systematic review and meta‐analysis of international studies. Neurology 88: 296–303.
Finger S, Clower WT. Victor Horsleyon «Trephiningin Pre-historic Times». Neurosurgery. 2001;28(4):911-918.
Gastaut H, Magnus O, Caveness W, et al. A proposed international classification of epileptic seizures. Epilepsia 1964; 5:297–306.
Gastaut H. Classification of the epilepsies. Proposal for an international classification. Epilepsia 1969;10 (Suppl.):14–21.
GBD 2016 Epilepsy Collaborators (2019). Global, regional and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol. 18: 357–375.
Global burden of epilepsy and the need for coordinated action at the country level to address its health, social and public knowledge implications. WHO Executive Board resolution EB136.R8. 2015.
Gregory D. Cascino, Joseph I. Sirven, William O. Tatum; Epilepsy 2021.,
Aidan Neligan, The long-term prognosis of epilepsy. 2011.
Mazina N. K., Mazin P.V., Kislitsyn Yu. V., Markova E. M. Pharmacoeconomic aspects of the use of rufinamide in patients with Lennox–Gastaut syndrome. Farmakoekonomika. Sovremennaya farmakoekonomika I farmakoepidemiologiya / pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology. 2016; 9 (1): 15-22. DOI:10.17749/2070-4909.2016.9.1.015-022.
Mil’chakova L. E. Epidemiology of epilepsy in individual subjects of the Russian Federation: epidemiology, clinic, social aspects, opportunities of optimization of pharmacotherapy. MD diss. Moscow. 2008; 32 s. URL: http://medical-diss.com/docreader/275258/a#?page=1. Accessed: 03.02.2017.
Murray, C.J., Vos, T., Lozano, R. et al. (2012). Disability‐adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197–2223.
Ngugi A, Bottomley C, Kleinschmidt I, Sander J, Newton C. Estimation of the burden of active and life-timeepilepsy: A meta-analytic approach. Epilepsia. 2010;51(5):883-890. https://doi.org/10.1111/j.1528-1167.2009.02481.x;
Patrick Kwan, yAlexis Arzimanoglou, zAnne T. Berg., et all; Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51(6):1069–1077, 2010 doi: 10.1111/j.1528-1167.2009.02397.x.
Penfield W, Flanigin H. Surgical therapy of temporal lobe seizures. ArchNeurolPsychiatry. 1950;64(4):491. https://doi.org/10.1001/archneurpsyc.1950.02310280003001.
Patrick Kwan, Alexis Arzimanoglou, zAnne T. Berg, xMartin J. Brodie,et al., Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51(6):1069–1077, 2010 doi: 10.1111/j.1528-1167.2009.02397.x
Robert S. Fisher, Carlos Acevedo, Alexis Arzimanoglou., et all., A practical clinical definition of epilepsy. Epilepsia, 55(4):475–482, 2014. doi: 10.1111/epi.12550.
Robert S. Fisher, J. Helen Cross, Jacqueline A. French., et all., Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4):522–530, 2017. doi: 10.1111/epi.13670.
Trenerry M.R., Loring D.W. The intracarotid amobarbital procedure. In: E. Wyllie. The treatment of epilepsy. Principles and practice. 4th ed. Lippincott W&W; 2006
Tian, N., Boring, M., Kobau, R. et al. Active epilepsy and seizure control in adults in United States 2013 and 2015. Morb. Mortal. Wkly. Rep. 67 (15): 437–442.
WHO Epilepsy Factsheet. Updated February 2017. URL: http://www.who.int/mediacentre/factsheets/fs999/en/. Accessed: 03.02.2017. 8.
Wiebe S, Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy. Nature Reviews Neurology.2012;8(12):669-677. https://doi.org/10.1038/nrneurol.2012.181].
